James Investment Research’s Harte-Hanks HHS Stock Holding History
Bought
Maintained
Sold
Other funds holding HHS
WCM
CS
KF
HIM
James Investment Research's HHS Position: Q2 2023 in Review
James Investment Research sold out of Harte-Hanks (HHS) in Q2 2023, closing a stake of 2,100 shares — an estimated $20K sold.
James Investment Research first reported a position in HHS in Q4 2022 and held it in 2 quarters. The position peaked at $25K in Q4 2022. 30 funds tracked by Wall St. Rank hold HHS as of Q2 2023.
- James Investment Research reported no remaining Harte-Hanks position as of Q2 2023 after selling out during the quarter.
- James Investment Research sold 2,100 Harte-Hanks shares in Q2 2023, an estimated $20K.
- James Investment Research first reported a position in Harte-Hanks in Q4 2022 and held it in 2 quarters.
- James Investment Research's Harte-Hanks position peaked at $25K in Q4 2022.
- 30 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2023.
Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.